.png)
.png)
Associate Professor
David Geffen School of Medicine at University of California
Disclosure(s): Merck Sharp & Dohme: Grant/Research Support
Kara Chew, MD, MS is Associate Clinical Professor of Medicine in the Division of Infectious Diseases and Center for Clinical AIDS Research and Education, Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles (UCLA). She completed internal medicine residency training at the University of California, San Francisco and infectious diseases fellowship training at UCLA, where she also earned a Master of Science in Clinical Research. Her research has focused on inflammation-mediated complications of HIV and hepatitis C infection and strategies for HIV remission. Since the onset of the COVID-19 pandemic, she has served in leadership roles for clinical trials of COVID-19 therapeutics, including Co-Chair of ACTIV-2/A5401, a global phase 2/3 adaptive platform trial of monoclonal antibodies and other therapies for the treatment of early SARS-CoV-2 infection in symptomatic non-hospitalized adults, a joint effort of the Federal COVID-19 Response, NIH Division of AIDS (DAIDS), and the AIDS Clinical Trials Group (ACTG).